NYSE:PRGO - Perrigo Stock Price, Forecast & News

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Perrigo declared a quarterly dividend on Monday, November 4th. Stockholders of record on Friday, November 29th will be given a dividend of $0.21 per share on Tuesday, December 17th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date is Wednesday, November 27th. View Perrigo's Dividend History.

Perrigo Company PLC (NYSE:PRGO) issued its earnings results on Wednesday, November, 6th. The company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.11. The firm had revenue of $1.19 billion for the quarter, compared to analyst estimates of $1.20 billion. Perrigo had a net margin of 5.24% and a return on equity of 9.39%. The business's quarterly revenue was up 5.1% on a year-over-year basis. During the same period in the prior year, the company posted $1.09 earnings per share. View Perrigo's Earnings History.

Perrigo is scheduled to release their next quarterly earnings announcement on Wednesday, February 26th 2020. View Earnings Estimates for Perrigo.

Perrigo updated its FY 2019 Pre-Market earnings guidance on Tuesday, January, 14th. The company provided EPS guidance of for the period. The company issued revenue guidance of $4.797-4.797 billion, compared to the consensus revenue estimate of $4.77 billion.

6 Wall Street analysts have issued twelve-month price targets for Perrigo's stock. Their forecasts range from $48.00 to $60.00. On average, they anticipate Perrigo's stock price to reach $53.80 in the next year. This suggests that the stock has a possible downside of 8.8%. View Analyst Price Targets for Perrigo.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Perrigo.

News headlines about PRGO stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Perrigo earned a news impact score of 1.7 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Perrigo.

Some companies that are related to Perrigo include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), Eli Lilly And Co (LLY), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Allergan (AGN), Mylan (MYL), Jazz Pharmaceuticals (JAZZ), Horizon Therapeutics (HZNP), The Medicines (MDCO), Nektar Therapeutics (NKTR), Zogenix (ZGNX) and Pacira Biosciences (PCRX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Perrigo investors own include Teva Pharmaceutical Industries (TEVA), Gilead Sciences (GILD), Mylan (MYL), Celgene (CELG), Allergan (AGN), Netflix (NFLX), Amgen (AMGN), Starbucks (SBUX), AbbVie (ABBV) and Johnson & Johnson (JNJ).

Perrigo's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Manning & Napier Group LLC (0.35%), State of Alaska Department of Revenue (0.07%), FTB Advisors Inc. (0.05%), Assenagon Asset Management S.A. (0.05%), Bowling Portfolio Management LLC (0.04%) and Moon Capital Management LLC (0.03%). Company insiders that own Perrigo stock include Geoffrey M Parker, Grainne Quinn, Jeffrey C Smith, Murray S Kessler, Ronald Craig Janish, Ronald Winowiecki, Svend Andersen, Theodore R Samuels II, Todd W Kingma and Uwe Roehrhoff. View Institutional Ownership Trends for Perrigo.

PRGO stock was sold by a variety of institutional investors in the last quarter, including Manning & Napier Group LLC, Commerzbank Aktiengesellschaft FI, State of Alaska Department of Revenue, Moon Capital Management LLC, Meag Munich Ergo Kapitalanlagegesellschaft MBH, FTB Advisors Inc. and Nisa Investment Advisors LLC. Company insiders that have sold Perrigo company stock in the last year include Grainne Quinn, Ronald Craig Janish, Ronald Winowiecki and Todd W Kingma. View Insider Buying and Selling for Perrigo.

PRGO stock was acquired by a variety of institutional investors in the last quarter, including Bowling Portfolio Management LLC, Assenagon Asset Management S.A., Sciencast Management LP and Contravisory Investment Management Inc.. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Jeffrey C Smith, Murray S Kessler, Svend Andersen, Theodore R Samuels II, Todd W Kingma and Uwe Roehrhoff. View Insider Buying and Selling for Perrigo.

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of PRGO stock can currently be purchased for approximately $59.02.

Perrigo has a market capitalization of $8.03 billion and generates $4.73 billion in revenue each year. The company earns $131 million in net income (profit) each year or $4.55 on an earnings per share basis. Perrigo employs 10,600 workers across the globe.View Additional Information About Perrigo.

The official website for Perrigo is http://www.perrigo.com/.

Perrigo's mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]